CATALYST PHARMACEUTICALS, INC.·4

May 5, 5:00 PM ET

COELHO PHILIP H 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed May 5, 2023

Insider Transaction Report

Form 4
Period: 2023-05-04
Transactions
  • Exercise/Conversion

    Common stock, par value $0.001 per share

    2023-05-04$0.79/sh+50,000$39,500204,887 total
  • Award

    Options to purchase Common Stock

    2023-05-0450,000260,500 total
    Exercise: $0.79Exp: 2023-06-15Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]Options vested in two annual tranches beginning on June 15, 2017.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 05-04-2023